This is a technical conference exclusively designed to help the professionals of the Pharma Industry to take critical decisions around controlling genotoxic impurities in drug development process. This is a two-day conference, divided into separate streams which will provide clarity on identification, analysis and regulatory specifications around genotoxic impurities.

The 4th edition of CPhI’s Annual Biosimilars will focus around the critical aspects of Process Development and Analytics. This conference has been carefully designed to discuss strategies for developing the first commercially successful molecule. Also introducing Commercialisation of Biosimilars Seminar – An exclusive one day seminar on commercialisation strategies for biosimilars in developed as well as emerging markets.

CPhI’s seminar on Biodegradable Polymers is specifically made to discuss problems around advance therapeutic application, techniques like coacervation and technologies like double emulsification and multiple emulsification for biodegradable implants, scale-up challenges and how to overcome them. Harald Liedtke, Technical Marketing Director, Biomaterials, Evonik Industries AG, Germany and Kevin Burton, Senior Director, R&D, Evonik Degussa Corporation, USA will discuss the most critical issues of microsphere development, scale-up challenges, hot melt extrusion and more.

The 2nd Annual Global Pharma Regulatory Summit 2013 brings a complete regulatory week focusing on the regulations for US, Europe and ROW markets & regulations for API, QbD, GDUFA, eCTD and many more growing concerns. The programme is enhcanced with interactive workshops on newly evolved GDUFA guidelines and practical study on eCTD lifecycle management.

A high-level strategic conference made to overcome challenges around crystallization and optimum utilisation of resources. Crystallization 2013 will focus on opportunities for further growth in developing high quality APIs.

After the success of Pharma IPR India 2012, CPhI India is glad to announce the 2nd Annual Pharma IPR India 2013, where patent regimes and market entry strategies will be discussed of over 10 countries including: USA, Europe, Japan, China, Korea, South Africa, Brazil, Mexico, Russia and South East Asia (Malaysia, Singapore, Thailand). This unique conference will address all critical intellectual property related queries in the pharma and biopharma sectors and provide on-the-spot solutions from leading global industry experts.

由中国工程院院士戴尅戎领衔提词："始于新，成于精"，植入介入医疗器械中国峰会2012已于7 月20 日在上海举办第一届。会议集合整个产业的最前沿人士，来自美国食品药品监督管理局，上海食品药品监督管理局、上海第九人民医院、南京军区总医院、美敦力、微创医疗、施乐辉等企业组织的演讲嘉宾一起探讨和分享了技术革新的最新成果、分析和透视了政策法规的最新进展，峰会整合植入介入医疗器械行业高端的百余位与会代表。暨植入介入医疗器械中国峰会2012 在上海和北京的成功举办，植入介入医疗器械中国峰会2013(上海)将于2013 年5 月23-24 日在上海召开。

CPhI introduces for the first time a conference designed for project managers in the pharma industry to help them ensure flawless implementation of project management, to actively monitor and control project activities within the defined cost, quality and time and to meet the increasing export demand.

The 3rd Annual PharmaLytica will help to learn best practice strategies around regulatory compliance, analytical method development and transfer, PAT, formulation analytical development, particle size characterisation and rapid microbiological techniques.

Pharma Sales Force Effectiveness and Automation conference will focus on the latest training modules to reduce attrition, best practice strategies for effective segmentation and targeting to maximise sales output, strategies for setting the right KPI’s to make the sales team responsible, robust CRM practices and latest techniques in analytics and reporting.